FRANKFURT, Germany - German drug and farm chemical company Bayer AG (BAYN) says it has signed a deal to acquire seed and weed-killer company Monsanto (MON) for $66 billion in cash.
Bayer says it is paying Monsanto shareholders $128 per share, which represents a 44 percent premium over Monsanto’s closing price on May 9, the day before a proposed deal was announced.
“We believe that this combination with Bayer represents the most compelling value for our shareowners, with the most certainty through the all-cash consideration,” said Monsanto chairman and CEO Hugh Grant in a joint statement.
The deal is subject to approval by Monsanto shareholders and anti-trust regulators.
Bayer said Wednesday the transaction brings together two different but complementary companies. Bayer makes a wide range of crop protection chemicals, while Monsanto is known for its seeds business.
Leverkusen-based Bayer said the merged companies’ agriculture business would have its seeds business and North American business headquarters in St. Louis, Missouri, where Monsanto is currently based.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.